Dr. Chang-Chun Ling


Dr. Ling graduated with a B.Sc. degree in Chemistry from the University of Lanzhou and obtained both his DEA (Diplôme d'Etudes Approfondies, 1988) and Ph.D. from the Université de Paris Sud (1991). He then spent several years as a post-doctoral fellow with Dr. Raphael Darcy at University College Dublin, Professor Stanislas Czernecki at the Université Pierre et Marie Curie and Professor David Bundle at the University of Alberta. After spending two years as a scientist at the Alberta Research Counci, he rejoined Professor Bundle's group as a Senior Research Associate (1998). In 2006, he joined the Department of Chemistry, University of Calgary as an Assistant Professor and promoted to the Associate level in 2012.

Over the years, Dr. Ling has acquired extensive research experience in several areas including nucelosides, cyclodextrins and modern carbohydrate chemistry. Currently, his research is focussed on the development of carbohydrate-based vaccines and therapeutics to prevent or treat infectious disease, cancer and autoimmune conditions. He is also a principal investigator at the Alberta Glycomics Centre where he leads a centre project towards the development of therapeutics to treat multi-drug resistant gastrointestinal diseases.